Regulatory T cells and plasmacytoid dendritic cells contribute to the immune escape of papillary thyroid cancer coexisting with multinodular non-toxic goiter

被引:0
|
作者
Hang Yu
Xiaomei Huang
Xiaosun Liu
Hailong Jin
Ge’er Zhang
Qing Zhang
Jiren Yu
机构
[1] The First Affiliated Hospital,Department of Gastrointestinal and Thyroid Surgery
[2] College of Medicine,undefined
[3] Zhejiang University,undefined
来源
Endocrine | 2013年 / 44卷
关键词
Papillary thyroid cancer; Multinodular non-toxic goiter; Tumor escape; Regulatory T cell; Plasmacytoid dendritic cell;
D O I
暂无
中图分类号
学科分类号
摘要
Immunosuppressive lymphocytes, such as regulatory T cells (Tregs) and plasmacytoid dendritic cells (pDCs), play crucial roles in tumor escape. To investigate the roles of Tregs and pDCs in papillary thyroid cancer (PTC) plus multinodular non-toxic goiter (MNG), thyroid tissue and blood samples from 30 patients with PTC plus MNG and 30 MNG alone were analyzed for CD4+ T cell, CD8+ T cell, FoxP3+ Treg, ICOS+FoxP3+ Treg, and pDC numbers by immunohistochemistry (IHC), immunofluorescence, and flow cytometry. Plasma concentration of the cytokines interleukin 10 (IL-10) and transforming growth factor β (TGF-β) were measured by enzyme-linked immunosorbent assay as well. Both in thyroid tissue and peripheral blood, the numbers of Foxp3+ Treg were significantly higher in patients with PTC plus MNG compared to patients with MNG alone; and as a prognostic marker, ICOS+Foxp3+ Tregs represent a stronger predictor of disease progression than the total numbers of Foxp3+ Tregs. Furthermore, a positive correlation between pDC and ICOS+Foxp3+ Treg numbers in tissue of patients with PTC plus MNG was observed, suggesting that PTC-derived pDCs may induce the differentiation of naive CD4+ T cells into ICOS+Foxp3+Tregs. This may be one of the mechanisms underlying tumor escape in PTC plus MNG patients. Our results suggest that Tregs and pDCs together contribute to the tumor escape in patients with PTC plus MNG.
引用
收藏
页码:172 / 181
页数:9
相关论文
共 45 条
  • [41] A Fluorescent Furan-based Probe with Protected Functional Groups for Highly Selective and Non-Toxic Imaging of HT-29 Cancer Cells and 4T1 Tumors
    Naderi, Parisa Mehdizadeh
    Zargoosh, Kiomars
    Qandalee, Mohammad
    Firuzi, Omidreza
    Behmadi, Hossein
    Hosseinkhani, Saman
    Ghafary, Soroush Moasses
    Duran-Valle, Carlos J.
    Lopez-Coca, Ignacio M.
    CHEMPLUSCHEM, 2024, 89 (09):
  • [42] Non-platelet-derived CXCL4 differentially regulates cytotoxic and regulatory T cells through CXCR3 to suppress the immune response to colon cancer
    Deng, Shaorong
    Deng, Qing
    Zhang, Yingjie
    Ye, Hao
    Yu, Xiaolan
    Zhang, Yang
    Han, Grace Y. Q.
    Luo, Ping
    Wu, Mingyuan
    Yu, Yan
    Han, Wei
    CANCER LETTERS, 2019, 443 : 1 - 12
  • [43] Expression of regulatory T cells in driver-gene-negative advanced non-small cell lung cancer as well as its effect on the therapeutic efficacy and prognosis of immune checkpoint inhibitors
    Chen, Y.
    Chen, S.
    Li, Y.
    Guo, X.
    Liang, Q.
    Yang, L.
    Lei, C.
    INTERNATIONAL JOURNAL OF RADIATION RESEARCH, 2024, 22 (02):
  • [44] Tumour immune evasion mechanism in non-small cell lung cancer by inducing Blimp-1 in CD4+CD25+Foxp-3+T regulatory cells
    Finotto, Susetta
    Tausche, Patrick
    Hohenberger, Katja
    Neurath, Laura
    Trufa, Denis I.
    Geppert, Carol I.
    Rieker, Ralf J.
    Sirbu, Horia
    Finotto, Susetta
    JOURNAL OF IMMUNOLOGY, 2021, 206
  • [45] ART1 tumor expression mediates immune resistance in non-small cell lung cancer by elimination of P2 x 7R+CD8 tissue resident memory T cells and conventional type I dendritic cells
    Wennerberg, Erik
    Hung, Clarey
    Valeta, Amanda
    McGraw, Timothy
    Demaria, Sandra
    Stiles, Brendon
    CANCER RESEARCH, 2020, 80 (16)